Regenerative medicine startup Pelage Pharmaceuticals has clinical data showing its small molecule activated hair follicle stem cells. GV led a Series A round that funded the UCLA spinout’s Phase 1 clinical trial and will also support Phase 2 testing this year.
Executives used to lean toward European regulators launching their products in that region. But after a decade of change, they now see the U.S. as a better option. While the FDA gets kudos, the other issue remains challenging: reimbursement.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The startup previously developed the Sleepio application, which is targeted at insomnia, and is offered to around 12 million users through partnerships with payers and employers like Boston Medical Center, Comcast and the NHS.
Patients across the entire University of California Health network are now being given the ability to download their medical data onto their Apple smartphones.
The brick-and-mortar retail industry isn't doing well. As shopping malls clear out, landlords are finding medical providers eager to take over the empty mall space.
An enormous ransomware attack has impacted organizations across the globe, including the National Health Service. U.K. hospitals resorted to diverting patients and using pen and paper for documentation.
Enlibrium's technology, licensed out of UCLA, will use diabetes drug metformin to shut down energy production in cancer cells - providing a potentially new frontline treatment for the disease.
The Los Angeles-based company developing its drug-resistant epilepsy system has officially backed out of its IPO plans.
If transmitting superbugs with scopes such a problem, why do we use the reusable devices?
UCLA Health is the latest healthcare organization to reveal that it has been the target of a malicious cyberattack.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Given the interest in digital health devices that can take on the challenge of obesity, a smart necklace under development by a group of UCLA engineers offers an interesting approach to helping people manage their eating habits. WearSens developers also see potential for the technology to be applied to other situations from smoking cessation to […]
UCLA Health will soon begin a pilot project with Seattle-based startup ActX that will integrate genomic patient data into its Epic EHR system, with the eventual intent of applying precision medicine to a large-scale patient base. ActX, founded in 2012 and just out of stealth mode six months ago, collects a patient’s genetic information by […]
The FCC is set to take up a vote on the hot-button issue of net neutrality this week, with much of the focus coming from tech and telecommunications companies. But healthcare leaders should be paying as close if not more attention. As the healthcare sector tilts increasingly toward telemedicine, mobile, cloud-based EHRs and data sharing […]
Since the news of the CRE (carbapenem-resistant enterobacteriaceae) infections at UCLA’s Ronald Reagan Medical Center on Wednesday, many are concerned about how the design of the duodenoscope used is difficult to sterilize. Seven people were infected with CRE and two have died. The device is often used to do procedures on the gallbladder, pancreatic ducts […]
At UCLA’s Ronald Reagan Medical Center, two people have died among seven patients who were infected with the antibiotic-resistant superbug known as CRE (Carbapenem-Resistant Enterobacteriaceae). The LA Times reported Wednesday that the number of infected patients may grow because nearly 180 patients who were treated from October to January could have potentially been exposed to […]
